|
|
|
Insider
Information: |
Gala Renee D |
Relationship: |
President & COO |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
223,014 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,880,081 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
223,014 |
|
|
Total
Value |
$7,880,081 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Theravance Biopharma, Inc. |
TBPH |
SVP, Chief Financial O... |
2018-11-20 |
157,657 |
2014-08-20 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2018-03-07 |
10,000 |
2018-03-06 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
President & COO |
2024-04-05 |
55,357 |
2020-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBPH |
Theravance Biopharma, Inc... |
SVP-Finance |
|
2014-08-20 |
4 |
D |
$26.98 |
$4,263 |
D/D |
(158) |
14,279 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
149,279 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2015-08-13 |
4 |
B |
$12.19 |
$60,950 |
D/D |
5,000 |
154,279 |
2.74 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2015-08-17 |
4 |
B |
$12.16 |
$60,800 |
D/D |
5,000 |
161,177 |
2.74 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2016-02-20 |
4 |
D |
$15.65 |
$204,264 |
D/D |
(13,052) |
148,125 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
238,125 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2016-05-20 |
4 |
D |
$20.55 |
$68,493 |
D/D |
(3,333) |
236,495 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2016-08-20 |
4 |
D |
$27.89 |
$120,094 |
D/D |
(4,306) |
232,189 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2016-11-20 |
4 |
D |
$31.96 |
$147,911 |
D/D |
(4,628) |
227,561 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
236,561 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2017-02-20 |
4 |
D |
$33.78 |
$344,928 |
D/D |
(10,211) |
226,350 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2017-05-20 |
4 |
D |
$36.83 |
$248,713 |
D/D |
(6,753) |
221,299 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2017-08-20 |
4 |
D |
$27.40 |
$185,005 |
D/D |
(6,752) |
214,547 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2017-11-20 |
4 |
D |
$28.58 |
$193,001 |
D/D |
(6,753) |
207,794 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
216,794 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-02-20 |
4 |
D |
$29.09 |
$156,708 |
D/D |
(5,387) |
211,407 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-03-06 |
4 |
B |
$15.30 |
$15,300 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-03-07 |
4 |
B |
$15.53 |
$139,802 |
D/D |
9,000 |
10,000 |
2.39 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
246,022 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-05-18 |
4 |
S |
$24.29 |
$242,877 |
D/D |
(10,000) |
236,022 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$516,101 |
D/D |
(21,230) |
214,792 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-08-14 |
4 |
S |
$27.74 |
$61,136 |
D/D |
(2,204) |
212,588 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-08-15 |
4 |
S |
$26.71 |
$1,110,655 |
D/D |
(41,539) |
171,049 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-08-20 |
4 |
D |
$26.95 |
$180,430 |
D/D |
(6,695) |
164,354 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
|
2018-11-20 |
4 |
D |
$24.79 |
$166,019 |
D/D |
(6,697) |
157,657 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|